Zdrowie i gospodarka · 3.11.2022
Advancing Premarket Safety Analytics Workshop; Request for Comments
The Food and Drug Administration (FDA, the Agency, or we) is requesting comments on the topics discussed at a public workshop entitled "Advancing Premarket Safety Analytics Workshop" held on September 14, 2022. The purpose of the public workshop was to present FDA's work and perspective on premarket review of safety data.